These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6394947)

  • 21. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
    Desatnik H; Habot-Wilner Z; Alhalel A; Moroz I; Glovinsky J; Moisseiev J
    Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual outcome of laser treatment in diabetic retinopathy.
    Shrestha S; Karki DB; Byanju R; Malla OK; Shrestha SM; Pradhananga CL
    Kathmandu Univ Med J (KUMJ); 2007; 5(1):72-80. PubMed ID: 18603990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Avitabile T; Longo A; Reibaldi A
    Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema.
    Margolis R; Singh RP; Bhatnagar P; Kaiser PK
    Acta Ophthalmol; 2008 Feb; 86(1):105-10. PubMed ID: 17608830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Indications and results of interstitial hypophyseal stereo-gammatherapy in the treatment of diabetic retinopathy].
    Debry G; Schaub C; Drouin P; Szikla G; Talairach J
    Neurochirurgie; 1977 Mar; 23(1):3-20. PubMed ID: 339116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visual prognosis after panretinal photocoagulation for proliferative diabetic retinopathy.
    Bek T; Erlandsen M
    Acta Ophthalmol Scand; 2006 Feb; 84(1):16-20. PubMed ID: 16445434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
    Kristinsson JK
    Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vitrectomy and proliferative diabetic retinopathy. Apropos of 66 eyes].
    Bouchard O; Zech JC; Trepsat C
    J Fr Ophtalmol; 1997; 20(4):263-70. PubMed ID: 9181137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of diabetic retinopathy by photocoagulation. Indications, methods and results].
    Chaine G; Massin-Korobelnik P
    Diabete Metab; 1993; 19(5):414-21. PubMed ID: 8056120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of pars plana vitrectomy for proliferative diabetic vitreoretinopathy on preexisting diabetic maculopathy.
    Hoerle S; Poestgens H; Schmidt J; Kroll P
    Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):197-201. PubMed ID: 11935276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema.
    Recchia FM; Ruby AJ; Carvalho Recchia CA
    Am J Ophthalmol; 2005 Mar; 139(3):447-54. PubMed ID: 15767052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [[Stereo GIHF-indications in failure of treatment of proliferative diabetic retinopathy by pan retinal photocoagulation].
    Constantinides G; Van-Hullebusch A; Lenski C; Schaub C
    Bull Soc Ophtalmol Fr; 1982 Apr; 82(4):603-4. PubMed ID: 6179648
    [No Abstract]   [Full Text] [Related]  

  • 33. [Stereotaxic hypophyseal implantation of Au198 and diabetic retinopathy. 52 cases].
    Cordier J; Debry G; Saudax E; Drouin P; Raspiller A
    Bull Soc Ophtalmol Fr; 1979; 79(8-9):733-5. PubMed ID: 400236
    [No Abstract]   [Full Text] [Related]  

  • 34. [Diabetic retinopathy: documentation, evaluation of its course and possibilities of treatment by photocoagulation].
    Körner F
    Schweiz Med Wochenschr; 1976 Jul; 106(31):1035-40. PubMed ID: 996526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Trial treatment of diabetic retinopathy by inhibition of pituitary somatotropin secretion with MAP].
    Bruni B; Bruni-Bocher K; Della Valle A; Gamba S
    Minerva Med; 1975 Mar; 66(21):1001-23. PubMed ID: 1124148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ophthalmologic indications and results of stereo-GIHF in diabetic retinopathy. 2].
    Debry G; Schaub C; Drouin P; Szikla ; Saudax E; Boujard O; Talairach J
    Neurochirurgie; 1977 Jul; 23(2):97-109. PubMed ID: 562480
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypophysectomy in diabetic retinopathy. The relationship between the degree of pituitary ablation and ocular response.
    Adams DA; Rand RW; Roth NH; Dashe AM; Gipstein RM; Heuser G
    Diabetes; 1974 Aug; 23(8):698-707. PubMed ID: 4604549
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy.
    Sharp PS; Fallon TJ; Brazier OJ; Sandler L; Joplin GF; Kohner EM
    Diabetologia; 1987 Apr; 30(4):199-207. PubMed ID: 2439401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term results of stereoghif in diabetic retinopathy].
    Malthieu D; Constantinides G; Turut P
    Bull Soc Ophtalmol Fr; 1990; 90(8-9):767, 770-3. PubMed ID: 2257651
    [No Abstract]   [Full Text] [Related]  

  • 40. Diabetic retinopathy.
    Kohner EM; Oakley NW
    Metabolism; 1975 Sep; 24(9):1085-102. PubMed ID: 1097858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.